SWELL cognitive behavioral therapy program for chronic insomnia in older Veterans

Implementing Cognitive Behavioral Therapy for Insomnia With Older Veterans: Function QUERI 3.0 (QUE 25-008)

Not applicable Interventional VA Office of Research and Development · NCT07216261

This project will try two ways of rolling out SWELL, a five-session CBT for chronic insomnia, to help older Veterans get and benefit from treatment.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment20 (estimated)
Ages60 Years and up
SexAll
SponsorVA Office of Research and Development Federal
Locations1 site (Durham, North Carolina)
Trial IDNCT07216261 on ClinicalTrials.gov

What this trial studies

The project uses a type III effectiveness–implementation hybrid and a parallel cluster randomized design to implement the adapted CBTI program (SWELL) across 20 VA facilities. Two implementation strategies (a foundational arm and a REACH arm) are compared while collecting data on clinical outcomes and sustainment. SWELL is a five-week, provider-delivered program focused on sleep schedules, limiting non-sleep activities in bed, healthy sleep habits, relaxation, and changing unhelpful sleep expectations. The trial leverages a training and supervision model that has enabled non-psychologists to deliver CBTI in prior work.

Who should consider this trial

Good fit: Older Veterans (typically aged 60 and up) who meet criteria for chronic insomnia, are medically and psychiatrically stable enough for multi-session CBTI, and receive care at a participating VA primary care clinic are ideal candidates.

Not a fit: Patients younger than 60, those with contraindications (for example uncontrolled seizure disorder or bipolar I) or who are too medically or psychiatrically unstable for multi-session CBTI, and non-VA patients are unlikely to benefit from participation.

Why it matters

Potential benefit: If successful, the project could increase access to an effective, age-friendly CBTI program for older Veterans and improve nighttime sleep and daytime functioning at scale.

How similar studies have performed: Prior trials of the adapted SWELL program showed significant improvements in nighttime sleep and daytime functioning lasting up to one year and demonstrated that non-psychologists can effectively deliver the therapy.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

Site Inclusion Criteria:

* Facility is part of the U.S. Department of Veterans Affairs (VA) health system.
* Primary care clinic providing care to older Veterans
* Clinic is located 25 miles from the nearest other VA clinic participating in the program
* Identified site champion (e.g., clinician or staff member) who is willing to assume required program responsibilities for implementation.

Patient Inclusion Criteria:

* meet diagnostic criteria for chronic insomnia disorder (with or without documented diagnosis)
* absence of a CBTI contraindication oi.e., comorbid condition that makes CBTI unsafe), including uncontrolled seizure disorders, bipolar disorder I, and/or too medically or psychiatrically unstable to engage in a multi-session treatment opatients can be referred to SWELL by a clinician or self-referred

Exclusion Criteria:

Site Exclusion Criteria:

* No members of the SWELL team working in the clinic

Patient Exclusion Criteria:

* younger than 60
* do not meet criteria for enrollment

Where this trial is running

Durham, North Carolina

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Chronic InsomniaSleep DisordersImplementation ScienceFunctional StatusQuality of LifeCognitive Behavioral TherapyVeterans
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.